Systemic Disease Impacts CNS Disease Control After SRS in Patients with Breast Cancer Brain Metastases (P1-6.006)
To compare the effect of early systemic disease progression (EP) vs. non-early progression (NEP) on central nervous system (CNS) failure-free survival (cFFS) and overall survival (OS) after stereotactic radiosurgery (SRS) among breast cancer patients with brain metastasis.
Authors
- Ajay Dhakal (ORCID: https://orcid.org/0000-0002-5140-158X)
- Sarah Sammons (ORCID: https://orcid.org/0000-0003-2589-9422)
- Carey K. Anders (ORCID: https://orcid.org/0000-0001-9165-4074)
- Alex Schick (ORCID: https://orcid.org/0000-0003-3015-9138)
- Myla Strawderman (ORCID: https://orcid.org/0000-0002-6016-968X)
- Dandan Zheng (ORCID: https://orcid.org/0000-0002-5207-8374)
- Kenneth Y. Usuki
- Sara Hardy (ORCID: https://orcid.org/0000-0002-8361-1688)
- Lauryn Hemminger
- Ruth O’Regan
- Michael P. Cummings (ORCID: https://orcid.org/0000-0002-1467-0334)
- Allison Magnuson (ORCID: https://orcid.org/0000-0002-0968-8265)
- Michael T. Milano (ORCID: https://orcid.org/0000-0001-8676-2855)
- Nimish Mohile
- David G. Hicks
- Jacqueline Behr
Institutions
- Cancer Institute (WIA) (IN)
- University of Rochester Medical Center (US)
- Dana-Farber Cancer Institute (US)
- Duke Medical Center (US)
- Duke Cancer Institute
- University of Rochester (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208591
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00